493 related articles for article (PubMed ID: 21272960)
41. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
42. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
43. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
[TBL] [Abstract][Full Text] [Related]
44. Classification of Alzheimer's Disease Using Whole Brain Hierarchical Network.
Liu J; Li M; Lan W; Wu FX; Pan Y; Wang J
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):624-632. PubMed ID: 28114031
[TBL] [Abstract][Full Text] [Related]
45. Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.
Yao Z; Zhang Y; Lin L; Zhou Y; Xu C; Jiang T;
PLoS Comput Biol; 2010 Nov; 6(11):e1001006. PubMed ID: 21124954
[TBL] [Abstract][Full Text] [Related]
46. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
47. Improving Alzheimer's Disease Classification by Combining Multiple Measures.
Liu J; Wang J; Tang Z; Hu B; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(5):1649-1659. PubMed ID: 28749356
[TBL] [Abstract][Full Text] [Related]
48. Convolutional Neural Network-based MR Image Analysis for Alzheimer's Disease Classification.
Choi BK; Madusanka N; Choi HK; So JH; Kim CH; Park HG; Bhattacharjee S; Prakash D
Curr Med Imaging Rev; 2020; 16(1):27-35. PubMed ID: 31989891
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
Platero C; Lin L; Tobar MC
Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
[TBL] [Abstract][Full Text] [Related]
50. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
Bakkour A; Morris JC; Dickerson BC
Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
[TBL] [Abstract][Full Text] [Related]
51. Hierarchical fusion of features and classifier decisions for Alzheimer's disease diagnosis.
Liu M; Zhang D; Shen D;
Hum Brain Mapp; 2014 Apr; 35(4):1305-19. PubMed ID: 23417832
[TBL] [Abstract][Full Text] [Related]
52. A 3D densely connected convolution neural network with connection-wise attention mechanism for Alzheimer's disease classification.
Zhang J; Zheng B; Gao A; Feng X; Liang D; Long X
Magn Reson Imaging; 2021 May; 78():119-126. PubMed ID: 33588019
[TBL] [Abstract][Full Text] [Related]
53. An extensible hierarchical graph convolutional network for early Alzheimer's disease identification.
Tian X; Liu Y; Wang L; Zeng X; Huang Y; Wang Z
Comput Methods Programs Biomed; 2023 Aug; 238():107597. PubMed ID: 37216716
[TBL] [Abstract][Full Text] [Related]
54. Structural MRI biomarkers for preclinical and mild Alzheimer's disease.
Fennema-Notestine C; Hagler DJ; McEvoy LK; Fleisher AS; Wu EH; Karow DS; Dale AM;
Hum Brain Mapp; 2009 Oct; 30(10):3238-53. PubMed ID: 19277975
[TBL] [Abstract][Full Text] [Related]
55. Cortical thickness in relation to clinical symptom onset in preclinical AD.
Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
[TBL] [Abstract][Full Text] [Related]
56. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease.
Li C; Wang J; Gui L; Zheng J; Liu C; Du H
J Alzheimers Dis; 2011; 27(2):281-90. PubMed ID: 21799248
[TBL] [Abstract][Full Text] [Related]
57. Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
Zhan Y; Chen K; Wu X; Zhang D; Zhang J; Yao L; Guo X;
J Alzheimers Dis; 2015; 47(4):1057-67. PubMed ID: 26401783
[TBL] [Abstract][Full Text] [Related]
58. Cognitive reserve and cortical thickness in preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Zhu Y; Wang MC; Brown T; Miller M; Albert M;
Brain Imaging Behav; 2017 Apr; 11(2):357-367. PubMed ID: 27544202
[TBL] [Abstract][Full Text] [Related]
59. Dimensionality reduced cortical features and their use in predicting longitudinal changes in Alzheimer's disease.
Park H; Yang JJ; Seo J; Lee JM;
Neurosci Lett; 2013 Aug; 550():17-22. PubMed ID: 23827219
[TBL] [Abstract][Full Text] [Related]
60. Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.
Andrade de Oliveira A; Carthery-Goulart MT; Oliveira Júnior PP; Carrettiero DC; Sato JR
J Alzheimers Dis; 2015; 43(1):201-12. PubMed ID: 25079801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
